LUGPA Series
LUGPA Virtual Crossfire Discussion and Debate Series
Presentations
Novel Imaging Tools for Prostate Cancer: Facilitating the Management of Patients with Rising PSA and Risk of Recurrence
Speakers: Gerald L. Andriole, MD, Distinguished Professor and Chief of Urologic SurgeryEdouard Trabulsi, MD, FACS, Professor and Vice Chair, Department of Urology Duration: 60 minutes
Presented on: November 7, 2019
*This session is not eligible for AMA PRA Category 1 CreditsTM
Speakers
Gerald L. Andriole, MD
Gerald L. Andriole, MD
Distinguished Professor and Chief of Urologic Surgery
Gerald L. Andriole, MD, is professor and chief of the Urologic Surgery Department with Washington University School of Medicine in St. Louis, Missouri. With over 30 years of consistent contributions in the areas of benign prostatic hyperplasia (BPH) and prostate cancer screening and prevention research, he has contributed to well over 400 peer-reviewed publications and abstracts. Dr. Andriole serves on the editorial boards of several prestigious journals. He is chairman of the Prostate Committee of the National Cancer Institute’s Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and of the Steering Committee of the REDUCE Prostate Cancer Prevention Trial. He received his medical degree from Jefferson Medical College in Philadelphia, Pennsylvania.Edouard Trabulsi, MD, FACS
Edouard Trabulsi, MD, FACS
Professor and Vice Chair, Department of Urology
Eduoard Trabulsi, MD, FACS, is professor of urology, director of the Division of Urologic Oncology, and vice chair in the Department of Urology of Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia, Pennsylvania. He specializes in all aspects of urologic oncology and robotic surgery, including prostate, bladder, kidney, and testicular cancer. Dr. Trabulsi’s research has been focused in advanced imaging for prostate and bladder cancer, including enhanced ultrasound and novel PET imaging, as well as appropriate use of postoperative radiotherapy after radical prostatectomy. He is former president of the Mid-Atlantic section of the American Urologic Association (AUA), and just completed service on the board of directors for the Society of Urologic Oncology.